Download presentation
Presentation is loading. Please wait.
1
November 18, 2010
2
Transient Erythroblastopenia of Childhood
3
Transient Erythroblastopenia of Childhood
Most common childhood acquired red cell aplasia Previously healthy children Age 1-3y/o
4
Etiology Poorly understood
Transient immunologic suppression of erythropoiesis Often follows viral illness
5
Lab findings Severe anemia Mild neutropenia in 20%
Reticulocytopenia However, 10% are in recovery at time of diagnosis Mild neutropenia in 20% Platelets normal or elevated MCV normal Hgb F levels normal
6
Treatment Nearly all recover 1-2 mos RBC transfusion may be necessary
Hgb < 5 Significant symptoms Cardiovascular compromise If > 1 transfusion needed, consider another dx Steroids NOT useful
7
Diamond Blackfan Anemia vs. Transient Erythroblastopenia
8
Diamond Blackfan Congenital hypoplastic anemia Dx 1st year of life
Average age 3mos Sporadic or familial Apoptosis of erythroid progenitor cells Increased circulating erythropoietin
9
DBA: Clinical Manifestations
May appear pale as neonate Profound anemia (symptomatic) by 6m/o Congenital anomalies in 50% Short stature Snub nose, wide-set eyes, thick upper lip “Intelligent Facies” Thumb abnormalities Cardiac and Eye abnormalities
10
DBA: Lab findings Macrocytosis Increased Hb F
Normal Folic Acid and B12 levels NO hypersegmentation of neutrophils Increased Hb F Erythrocyte adenosine deaminase (ADA) increased Occasionally low plts or WBCs Reticulocytopenia
11
DBA: Treatment Prednisone Non-responders
75% respond initially Mechanism unknown Non-responders Transfusion q4-8wks Stem cell transplant as last resort
12
Prognosis Survival 40yrs
Complications of stem cell transplant, corticosteroids, iron overload ?Premalignant Syndrome? AML Myelodysplasia Osteosarcoma
13
DBA TEC Age Infancy 1-3y/o Inherited? Acquired Antecedent illness No Viral illness Abnormal facies/anomalies Yes: 25-50% RBC Adenosine Deaminase High Normal MCV (?high in recovery) Hgb F (?high in recovery
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.